enclomiphene citrate
AssetAlso Androxal
Selective estrogen receptor modulator stimulating endogenous testosterone production
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- ESR2
- 1
- Indication
- 230
- Trials
- 1
- Developer
Indications
1Secondary hypogonadism
Phase 2, Completed, NCT01386606, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials230
- Evidence for its targets3
- Competitors12
- Signals4
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 2 sources